We designed a new way of tapering antidepressants, but why won't the health authorities recognise its value? - The Pharmaceutical Journal

Submitted by Anonymous (not verified) on Mon, 10/12/2020 - 07:00

We designed a new way of tapering antidepressants, but why won't the health authorities recognise its value?  The Pharmaceutical Journal